Vise Technologies, Inc. Myriad Genetics Inc Transaction History
Vise Technologies, Inc.
- $771 Million
- Q3 2024
A detailed history of Vise Technologies, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Vise Technologies, Inc. holds 13,367 shares of MYGN stock, worth $207,054. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,367
Previous 11,651
14.73%
Holding current value
$207,054
Previous $284,000
28.52%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
253Shares Held
90.9MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$235 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$160 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$104 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$80.2 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$72.9 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.25B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...